Eli Lilly and Company & Morgan Stanley
3 shared events · Importance 3 · Last updated Jun 12, 2026
Live sentiment trends, interaction importance charts, and action volume tracking available on the
Ergen Dashboard
Business
Eli Lilly and Company: Eli Lilly and Company>>> advanced after positive trial results for its next-generation obesity drug, retatrutide, which showed benefits beyond weight loss.
Morgan Stanley: Morgan Stanley's strategist, Michael Wilson, offered an optimistic outlook on the market, suggesting the recent correction was healthy.
May 20, 2026 · 72 articles
Business
Eli Lilly and Company: Eli Lilly and Company is mentioned as one of the companies that SpaceX's valuation will surpass, emphasizing the magnitude of SpaceX's market entry.
Morgan Stanley: Morgan Stanley was a joint book-running manager for the SpaceX IPO, helping to manage the offering and earning substantial fees.
Mar 09, 2018 · 538 articles
Business
Eli Lilly and Company: Eli Lilly is mentioned as a prior acquirer of Point Biopharma and as a former partner with Lantheus on a PSMA-directed therapeutic that was abandoned after an unfavorable trial.
Morgan Stanley: Morgan Stanley served as Lantheus' lead financial adviser, playing a key role in the transaction.
Aug 03, 2026 · 7 articles
ERGEN INTELLIGENCE
Explore this relationship live
Track how Eli Lilly and Company and Morgan Stanley interact across events, view sentiment trends, and discover connected entities.
Open Dashboard